Study Design: Retrospective database study. Objectives: Analysis of economic and demographic data concerning lumbar disc arthroplasty (LDA) throughout the United States to improve value-based care and health care utilization.
Introduction
Lower back pain is one of the most common causes of disability in the United States. 1 Although the vast majority of lower back pain is successfully managed with conservative modalities, spinal arthrodesis of the lumbar spine is frequently performed when surgical treatment is indicated. Recent studies have shown significant increases in the use of fusion procedures over the past decade 2, 3 ; however, complications such as adjacent-level disease, pseudarthrosis, and persistent pain have resulted in 5-year reoperation rates of more than 19%.
Lumbar disc arthroplasty (LDA) was introduced in the mid2000s as an alternative to spinal fusion with preservation of joint mobility and a potentially decreased risk of complications. LDA was expected to transform the landscape of lumbar spinal surgery; however, despite clinical studies showing comparable or better clinical outcomes, there has been a progressive decline in the use of LDA since its approval by the US Food and Drug Administration. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Awe and colleagues found that at its peak, post Food and Drug Administration approval, the volume of LDA procedures was only 3% of the number of posterolateral fusion performed that year. 5 Although surgical treatment accounts for a relatively small part of total hospital costs, a number of studies have reported the increasing use of surgical interventions for lower back pain over the past decade. 2, 15 Furthermore, the United States has the highest rate of spinal surgery worldwide. 3 Given the changes in the health care system and the increasing focus on health care utilization and value-based care, it has become increasingly important to understand the patterns of surgical treatment for lower back pain, as it accounts for a growing proportion of total health care costs.
The purpose of this study was to determine the trends in primary and revision LDA over the recent decade and evaluate the unexpected decline in procedure utilization. By performing a longitudinal analysis of an administrative inpatient database, we may understand the yearly trends and economic data surrounding LDA and revision LDA. An appreciation for the yearly national aggregate cost of the procedure is of significant importance to surgeons, policy makers, and hospital administrators. Thus, in this study, we utilized data from the National Inpatient Sample (NIS) database to compare a large, national cohort of patients who underwent primary and revision LDA from 2005 to 2013.
Methods

Data Source
Data was collected from the NIS database between 2005 and 2013 across 44 states. The NIS database was developed for the Healthcare Cost and Utilization Project and constitutes the largest all-payer inpatient database in the United States. The database represents a 20% sample of discharges from US hospitals (excluding rehabilitation and long-term acute care hospitals), which is weighted to provide national estimates.
Patient Selection and Characteristics
The NIS database was queried for primary LDA Demographic and economic data were obtained for both primary and revision LDA. Insurance types included Medicare, Medicaid, private, uninsured, and other. The "other" category included workman's compensation, TRICARE/CHAMPUS, CHAMPVA, Title V, and a number of other government programs. The annual number of surgeries, patient age, sex, total charges, total costs (in then-year dollars), insurance type, length of stay (LOS), location, and frequency of routine discharge, defined as home discharge without visiting nursing care, were recorded. Revision burden was defined as the ratio of revision procedures (removal, revision, supplemental fixation, or reoperation at the index level) to the sum of primary and revision procedures. Aggregate charges or the "national bill" was defined as the sum of all charges for all hospital stays in the United States. Total charges were converted to costs using cost-to-charge ratios based on hospital accounting reports from the Centers for Medicare and Medicaid Services. Costs reflect the actual costs of production, while charges represent what the hospital billed for the case. Because cost data was not available in 2005, our cost analysis was restricted to 2006 through 2013.
Descriptive statistics were performed to compare variables. Two-sample Student's t test was employed to analyze the difference in continuous variables, and w 2 test or Fisher's exact test was employed for categorical variables. Findings were considered statistically significant when P < .05. Analysis was conducted using IBM SPSS Statistics Version 24. The NIS database is de-identified and was therefore deemed exempt by our institutional review board. Primary LDA patients had a shorter LOS and a higher rate of routine discharges, defined as discharge home without home nursing care. The mean LOS for primary LDA over the 9-year period was 2.6 days (SE ¼ 0.06; range ¼ 2.3-3.3 days), while mean LOS for revision LDA was 3.7 days (SE ¼ 0.2; range ¼ 2.9-4.4 days; P ¼ .0003; Figure 2 ). The mean percentage of patients with routine discharge after primary LDA was 91% (SE ¼ 1.0%; range ¼ 86% to 94%) compared to 77% after revision LDA (SE ¼ 2.4%; range ¼ 56% to 89%; P ¼ .02; Figure 3 ). The LOS and routine discharges for primary LDA did not widely vary each year; however, there were large fluctuations in revision LDA.
Results
An estimated 12 957 patients (SE ¼
The mean total hospital cost for both primary and revision LDA Figure 4 ). Over the 8-year period, the mean cost per primary LDA procedure was significantly more expensive than the mean cost per revision LDA ($21 162 vs $16 628, respectively; P ¼ .006).
The aggregate national charges, or the "national bill," decreased over the study period for primary LDA and totaled The majority of patients receiving primary LDA were between the ages of 18 and 44 years (68%) and 45 and 64 years (30%). Males received a significantly larger portion of primary LDA procedures as compared to females (54% and 44%, respectively; P ¼ .0009). Private insurance accounted for 52% of payer types for primary LDA, while "other" accounted for 35%. There was an even distribution of primary LDA cases performed at teaching and nonteaching hospitals (52% vs 48%, respectively; P < .05). The LDA mean revision burden was 11.6% (range ¼ 6.0% to 24.3%; Figure 7 ). The largest yearly increase in revision burden was 6.6% in 2011 to 20.4% in 2012.
Discussion
The trends observed in the current analysis of the NIS database corroborate the current literature. Yoshihara and colleagues retrospectively analyzed the NIS from 2000 to 2009, collecting data for patients 18 years or older with a primary diagnosis of lumbar degenerative disc disease (DDD). The authors found that surgical treatment for lumbar DDD increased 2.4-fold in the United States over the study period, with a decrease in LDA and an increase in fusion procedures. 2 Similarly, Awe and colleagues analyzed the NIS database from 2000 to 2008. The authors reported steady growth in lumbar spinal fusion with a 28% decrease in the number of lumbar arthroplasty procedures. In this study, LDA comprised less than 2% of lumbar spine stabilization procedures-a minimal impact on the overall spine market. 5 The decreasing use of LDA has been attributed to a narrow specificity of indications necessary to promote successful outcomes, limited data on long-term outcomes and complications, and most significantly insurance coverage. 16 Although many surgeons share enthusiasm for LDA 17 and long-term studies have shown equivalence or, in some instances, superiority to fusion, insurers have been reluctant to reimburse for such procedures. 10 The Centers for Medicare and Medicaid Services does not cover LDA in the Medicare population over 60 years of age. 18 Similarly most private insurance companies in the United States do not provide coverage. The lack of coverage and reimbursement is undoubtedly contributed to the decline in procedural volume.
Another issue related to the low rates of adoption for LDA is the contentious indication for the procedure: degenerative disc disease (DDD). Because of the lack of consensus regarding the validity of the diagnosis in the setting of back pain, it becomes increasingly difficult to receive reimbursement for the procedure. This may have lead to the low procedural volume for LDA. Additionally, the complexity of the surgical procedure along with the fear of complications may have also played a role in the declining use of LDA. The combination of all of these factors have likely led to the reduction in procedural volume found in the current study.
Correspondingly, the decline in LDA comes at a time when total spinal fusion procedures in the United States are increasing. 2, 3, 19 Jancuska and colleagues reported that the number of fusions per year increased 55% from 2005 to 2014, with the ratio of fusion to nonfusion surgeries increasing from 0.88 to 2.67 at high-volume hospitals, from 0.84 to 2.30 at mediumvolume hospitals, and from 0.66 to 1.52 at low-volume hospitals. 19 In terms of specific procedures, Yoshihara et al utilized the NIS database and found anterior-posterior lumbar fusions increased 3.0-fold and posterior lumbar fusions increased 2.8-fold between 2000 and 2009. 2 Similarly, Pannell and colleagues reported a significant increase in posterior lumbar interbody fusions (P < .0001), posterior lumbar fusions (P ¼ .012), and anterior lumbar interbody fusions (P < .0001) from 2004 to 2009 within the NIS database. 3 These studies demonstrate that the overall increase in spinal fusions is, at least partially, compensating for the decline in LDA observed in the current study.
Since the introduction of LDA, numerous well-designed studies have shown that these devices are noninferior when compared with spinal fusion procedures. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In a recent study, Park and colleagues reported that LDA had clinical success rates of 76.9% and satisfaction rates of 87.2% at 10-year follow-up, emphasizing a strict patient selection process mandatory for success. 16 Moreover, a meta-analysis of randomized controlled trials reported that total disc replacement showed significant superiority to fusion for the treatment of lumbar DDD in terms of Oswestry Disability Index scores, patient satisfaction, Visual Analog Scale satisfaction, narcotic use, overall success rate, and complications. 20 However, the narrower surgical indications, absence of health insurance support, and technical surgical challenges have likely contributed to the poor adoption of LDA. 5 Understanding the cost-effectiveness of LDA in the context of the US health care system is critical in delivering valuebased care. Levin and colleagues reported that patients undergoing 1-level ProDisc total disc replacement spent significantly less time in the operating room and had less estimated blood loss than patients who had circumferential fusions. Furthermore, charges were significantly lower for the total disc replacement group compared to the fusion group, resulting in overall cost savings. 21 Similarly, in 3-level spinal procedures, LDA patients benefited from 49% lower in-hospital costs compared with patients undergoing arthrodesis. 22 Understanding the current trends, economic data, and clinical outcomes for LDA is critical in the determination of cost-effectiveness and appropriate allocation of health care resources. These issues raise an important concern for the ability of payers to limit a procedure with confirmed value and cost-effectiveness, thereby limiting patients access to care. Although aggregate expenditure on LDA have decreased over the past decade, overall costs for the treatment of LBP have increased significantly, suggesting that payer denial of LDA has not impacted costs overall.
The current study, which is a longitudinal analysis of an administrative inpatient database, is not designed to determine the cause of the observed trends, such as the increased cost of LDA procedures. Although this study was not designed to determine the cause of the increased inpatient cost over the study period, it is important to keep in mind that health care industry trend rates are much higher than the national inflation rate. In 2016, the global average medical trend rate was 8.1% per year compared to the global inflation rate of 2.9%. 23 Revision burden is a critical element in the analysis of a surgical implant. During the study period the overall revision burden increased, while disc replacements decreased overall. Several factors may have influenced this trend, including the decline in primary procedures. The decline in primary LDA would account for the increase in revision burden through the ratio calculation. The increase in revision burden may also be explained by an increasing proportion of revision procedures. Revision procedures may have increased over time because of the accumulation of primary surgeries requiring reoperation, as LDA is a relatively new procedure.
Many of the limitations of this study are due to the intrinsic limitations of large patient databases. The NIS database does not include physician-based fees and costs are calculated from hospital-specific cost-to-charge ratios, which may exaggerate surgical cases. Still these hospital-specific cost-to-charge ratios have been internally validated by the Agency for Healthcare Research and Quality. Inherent to a large study, the surgeries were performed by a large variety of surgeons, allowing for differences in surgical technique and potential indication bias. Furthermore, there can be potential inaccuracies of ICD-9 CM billing records, errors transferring data from hospital records to administrative records, underreporting of procedures, or exclusion of missing cases in the NIS database.
In this analysis of the NIS database, the rate of primary LDA and revision LDA progressively declined over a recent decade. In addition, mean hospital costs increased, while aggregate national charges decreased for primary LDA. Our findings corroborate the trend in LDA usage in the current literature, which may be a direct consequence of limited coverage from public and private insurance companies. Although many studies have reported noninferior clinical outcomes and costeffectiveness of LDA in comparison to lumbar arthrodesis, prospective randomized trials are necessary to more rigorously evaluate the long-term outcomes and cost-effectiveness of LDA from a national health care perspective.
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